Nachrichten zur Illumina Inc. Aktie

Illumina, Inc. 2026 Q1 - Results - Earnings Call Presentation

…

Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended March 2026, but…

Illumina (ILMN) Q1 2026 Earnings Transcript

Image source: The Motley Fool.DateThursday, Apr. 30, 2026 at 4:30 p.m. ETCall participantsChief Executive Officer — Jacob ThaysenChief Financial Officer…

Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now?

TEM and ILMN battle in precision oncology, but stronger stock gains, valuation and earnings outlook position ILMN as the more…

ILMN Stock Gains Following Expanded Collaboration With Labcorp

Illumina gains after expanding Labcorp collaboration to boost NGS oncology adoption, broaden testing access, and drive growth in precision cancer…

SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript

Image source: The Motley Fool.DATEMarch 3, 2026, 8 a.m. ETCALL PARTICIPANTSChief Executive Officer — Jurgi CamblongChief Financial Officer — George…

TEM vs. ILMN: Which MedTech Stock Offers Greater Upside?

Tempus posts 83% Q4 revenue growth and a 49.6% implied upside as AI-driven oncology gains steam - can it outpace…

Illumina Q4 Earnings & Revenues Top Estimates, Stock Dips

ILMN tops Q4 EPS and revenue estimates, posts 42% profit jump, but shares slide 10% on margin concerns despite 2026…

Illumina (ILMN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter…

Boston Scientific (BSX) Earnings Transcript

Image source: The Motley Fool.DATEWednesday, February 4, 2026, 8 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Michael F. MahoneyExecutive…

Stocks Slide on CPI, Traders Boost June Fed Rate-Cut Odds | The Close 1/13/2026

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after…

Illuminas New Connected Multiomics Platform Set to Boost Its Stock

ILMNs Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.…

Illumina Aktie: Comeback in Sicht? 2026 könnte überraschen!

New York (www.aktiencheck.de) - Illumina-Aktienanalyse von TD Cowen:TD Cowen habe das Kursziel für die Aktie von Illumina Inc. (ISIN: US4523271090,…

Illumina Aktie: AXELIOS mit Roche als Gamechanger - Kursziel steigt auf 130 USD

Bad Marienberg (www.aktiencheck.de) - Illumina-Aktienanalyse von Canaccord: Kursziel 130 USD rückt strategische Weichen für 2026Die Illumina-Aktienanalyse von Canaccord sorgt kurz…

PCCA Partners with Pillumina® to Advance Environmental Sustainability in Compounding with Aluminum Pill Bottles

Houston, TX, Dec. 17, 2025 (GLOBE NEWSWIRE) -- PCCA today announced a new collaboration with?Pillumina®,?an innovator in sustainable…

Bet on These 3 Stocks With Upgraded Broker Ratings Amid Uncertainties

Illumina, Commercial Metals and Newmont have all seen broker upgrades, signaling bullish momentum amid market uncertainties.…

Pivotal-Point Nachverfolgung Illumina (ILMN): Genomik-Pionier übertrifft in Q3 mit 1,34 USD die EPS-Prognose und setzt auf Proteomik!

Illumina ist ein weltweit führender Anbieter von Systemen zur Genomsequenzierung und Array-Technologie. Die Produkte des Unternehmens werden in Forschung und…

Illumina - Steigende Behandlungszahlen schieben Ergebnis weiter an!

Geschäftstreiber: Der Gensequenzierungsspezialist Illumina (ILMN) hat sich als einer der technologisch führenden Player in diesem Wachstumsmarkt etabliert. Mit Hilfe der…

Hopeful Well Find Long-term Solution On China: Illumina CEO

Illumina reported revenue growth and raised its financial guidance for the second straight quarter. Illumina CEO Jacob Thaysen acknowledged the…

Compared to Estimates, Illumina (ILMN) Q3 Earnings: A Look at Key Metrics

The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended September 2025, but…

Illumina Aktie: Stimmung hellt sich auf - reicht das für ein Comeback?

London (www.aktiencheck.de) - Illumina-Aktienanalyse von Barclays:Die Analysten von Barclays haben das Kursziel für die Aktie von Illumina Inc. (ISIN: US4523271090,…

TEM vs. ILMN: Which Precision Oncology Stock Is Worth Buying Now?

As precision oncology advances, Tempus and Illumina lead the way with innovation. Which stock shows stronger growth momentum now?…

Illumina Stock May Benefit From New Agreement to Acquire SomaLogic

ILMN jumps 2.9% after striking a $350M deal to acquire SomaLogic and boost its fast-growing multiomics strategy.…

Standard BioTools stock soars after selling SomaLogic to Illumina for $425M By Investing.com

Standard BioTools stock soars after selling SomaLogic to Illumina for $425M…

Illumina, Inc. (ILMN) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

…

Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software

ILMNs latest software features easy-to-use oncology apps, enhanced multiomics pipelines and AWS F2 support, enabling faster turnaround times.…

illumin Holdings Inc. Announces Date for First Quarter 2025 Financial and Operating Results

TORONTO and NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX: ILLM, OTCQB: ILLMF) (“illumin”…

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment community Former Illumina, MSCI, and…

Illumina Aktie: Harter Brocken zu erwarten?

Illumina verzeichnet deutliche Kursverluste, während Analysten gespaltene Meinungen zur Zukunft des Genforschungsspezialisten haben. Entscheidende Quartalszahlen stehen bevor. Die Illumina-Aktie se...…

Got $3,000? 2 Artificial Intelligence (AI) Stocks to Buy and Hold for the Long Term

Its hard to watch the value of your investments falter in a short period, but everyone is in the same…

Corvex’s Meister joins the board at Illumina. Here’s how he can create value for shareholders

Keith Meister, Corvex Managements chief investment officer, will join Illuminas board starting March 28. Hes no stranger to the world…

Illumina Aktie: Neuer Vorstand, alte Herausforderungen

Charlotte (www.aktiencheck.de) - Illumina-Aktienanalyse von BofA Securities: Rating und Kursziel Bank of America bewertet die Aktie von Illumina Inc. (ISIN: US4523271090, WKN:…

Illumina shares rise on WSJ report activist investor Meister will join board By Investing.com

Illumina shares rise on WSJ report activist investor Meister will join board…

Activist investor Keith Meister to join Illumina’s board, WSJ reports By Reuters

Activist investor Keith Meister to join Illumina’s board, WSJ reports…

Activist investor Keith Meister to join Illuminas board, WSJ reports

Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott Gottlieb will…

Illuminas AGD Project Completes 250,000 Whole Genomes: Stock to Gain?

ILMN-NashBios AGD initiative achieves the milestone of completing 250,000 whole genomes.…

Illumina Aktie: China-Risiken abgebaut, aber neue Herausforderungen in Sicht?

London (www.aktiencheck.de) - Illumina-Aktienanalyse von Barclays: Aktuelle Bewertung Die Analysten von Barclays bestätigen ihr "underweight"-Rating für Illumina Inc. (ISIN: US4523271090, WKN: 927079,…

Illumina lowers outlook due to China sales ban, to cut $100 million in costs

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced…

Canaccord maintains Illumina stock hold with $135 target By Investing.com

Canaccord maintains Illumina stock hold with $135 target…

Stocks making the biggest moves premarket: Nvidia, Tesla, Target, Illumina and more

These are the stocks posting some of the largest moves in premarket trading.…

China bans imports of Illumina’s gene sequencers By Reuters

China bans imports of Illumina’s gene sequencers…

China Bans Illumina Sequencer Imports as Trade Tensions Rise

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US…

Tariffs, Cut Funding Spur Illumina’s Worst Month in 23 Years

Illumina Inc. investors suffered back-to-back setbacks each week in February, as the gene-sequencing company capped off its worst month in…

HSBC downgrades Illumina on China risks, funding concerns By Investing.com

HSBC downgrades Illumina on China risks, funding concerns…

Illumina, Inc. (ILMN) AGBT Investor Session Conference (Transcript)

…

Genomic Data Analysis and Interpretation Market Research 2025-2033: Syngenta Group Leads, Followed by Amgen, Monsanto (Bayer), and Illumina

Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to…

dpa-AFX ProFeed